Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

Glenda E. Gray, Fatima Laher, Tanya Doherty, Salim Abdool Karim, Scott Hammer, John Mascola, Christopher Beyrer, Larry Corey

Research output: Contribution to journalArticle

Abstract

In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date—a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.

Original languageEnglish (US)
Article numbere1002372
JournalPLoS Biology
Volume14
Issue number3
DOIs
StatePublished - Mar 2 2016

    Fingerprint

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Gray, G. E., Laher, F., Doherty, T., Abdool Karim, S., Hammer, S., Mascola, J., Beyrer, C., & Corey, L. (2016). Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? PLoS Biology, 14(3), [e1002372]. https://doi.org/10.1371/journal.pbio.1002372